miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer
Authors:
- 1 September 2015
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 464 (4) , 1302-1308
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cellsOncotarget, 2014
- Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abirateroneOncotarget, 2014
- Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathwayOncotarget, 2014
- NBNgain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancerOncotarget, 2014
- A screen for transcription factor targets of Glycogen Synthase Kinase-3 highlights an inverse correlation of NFκB and Androgen Receptor Signaling in Prostate CancerOncotarget, 2014
- Protein Tyrosine Kinase 7 (PTK7) as a Predictor of Lymph Node Metastases and a Novel Prognostic Biomarker in Patients with Prostate CancerInternational Journal of Molecular Sciences, 2014
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Generation and physiological roles of linear ubiquitin chainsBMC Biology, 2012
- PSA and other tissue kallikreins for prostate cancer detectionEuropean Journal of Cancer, 2007
- A ubiquitin ligase complex assembles linear polyubiquitin chainsThe EMBO Journal, 2006